Drug Shortage Report for IMITREX

Last updated on 2018-02-08 History
Report ID 11253
Drug Identification Number 02212188
Brand name IMITREX INJECTION 12MG/ML
Common or Proper name Sumatriptan succinate injection
Company Name GLAXOSMITHKLINE INC
Market Status MARKETED
Active Ingredient(s) SUMATRIPTAN
Strength(s) 12MG
Dosage form(s) LIQUID
Route of administration SUBCUTANEOUS
Packaging size 2x0.5mL (Refill pack/L’emballage de recharge)
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2017-06-29
Estimated end date 2018-02-28
Actual end date 2018-02-07
Shortage status Resolved
Updated date 2018-02-08
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2018-02-08 French Compare
v20 2018-02-08 English Compare
v19 2018-01-04 French Compare
v18 2018-01-04 English Compare
v17 2017-10-04 French Compare
v16 2017-10-04 English Compare
v15 2017-06-30 French Compare
v14 2017-06-30 English Compare
v13 2017-06-30 English Compare
v12 2017-06-28 French Compare
v11 2017-06-28 English Compare
v10 2017-06-27 English Compare
v9 2017-06-21 French Compare
v8 2017-06-21 English Compare
v7 2017-06-06 French Compare
v6 2017-06-06 English Compare
v5 2017-05-31 French Compare
v4 2017-05-31 English Compare
v3 2017-05-25 French Compare
v2 2017-05-25 English Compare

Showing 1 to 20 of 21